Sgroi DC - Search Results

1

Expressed Gene Fusions as Frequent Drivers of Poor Outcomes in Hormone Receptor-Positive Breast Cancer.

Matissek KJ, Onozato ML, Sun S, Zheng Z, Schultz A, Lee J, Patel K, Jerevall PL, Saladi SV, Macleay A, Tavallai M, Badovinac-Crnjevic T, Barrios C, Beşe N, Chan A, Chavarri-Guerra Y, Debiasi M, Demirdögen E, Egeli Ü, Gökgöz S, Gomez H, Liedke P, Tasdelen I, Tolunay S, Werutsky G, St Louis J, Horick N, Finkelstein DM, Le LP, Bardia A, Goss PE, Sgroi DC, Iafrate AJ, Ellisen LW. Matissek KJ, et al. Among authors: sgroi dc. Cancer Discov. 2018 Mar;8(3):336-353. doi: 10.1158/2159-8290.CD-17-0535. Epub 2017 Dec 14. Cancer Discov. 2018. PMID: 29242214

2

In vivo gene expression profile analysis of human breast cancer progression.

Sgroi DC, Teng S, Robinson G, LeVangie R, Hudson JR Jr, Elkahloun AG. Sgroi DC, et al. Cancer Res. 1999 Nov 15;59(22):5656-61. Cancer Res. 1999. PMID: 10582678

3

Frequent met oncogene amplification in a Brca1/Trp53 mouse model of mammary tumorigenesis.

Smolen GA, Muir B, Mohapatra G, Barmettler A, Kim WJ, Rivera MN, Haserlat SM, Okimoto RA, Kwak E, Dahiya S, Garber JE, Bell DW, Sgroi DC, Chin L, Deng CX, Haber DA. Smolen GA, et al. Among authors: sgroi dc. Cancer Res. 2006 Apr 1;66(7):3452-5. doi: 10.1158/0008-5472.CAN-05-4181. Cancer Res. 2006. PMID: 16585167

4

The p63/p73 network mediates chemosensitivity to cisplatin in a biologically defined subset of primary breast cancers.

Leong CO, Vidnovic N, DeYoung MP, Sgroi D, Ellisen LW. Leong CO, et al. J Clin Invest. 2007 May;117(5):1370-80. doi: 10.1172/JCI30866. Epub 2007 Apr 19. J Clin Invest. 2007. PMID: 17446929 Free PMC article.

5

The prognostic biomarkers HOXB13, IL17BR, and CHDH are regulated by estrogen in breast cancer.

Wang Z, Dahiya S, Provencher H, Muir B, Carney E, Coser K, Shioda T, Ma XJ, Sgroi DC. Wang Z, et al. Among authors: sgroi dc. Clin Cancer Res. 2007 Nov 1;13(21):6327-34. doi: 10.1158/1078-0432.CCR-07-0310. Clin Cancer Res. 2007. PMID: 17975144

6

Hypoxia regulates TSC1/2-mTOR signaling and tumor suppression through REDD1-mediated 14-3-3 shuttling.

DeYoung MP, Horak P, Sofer A, Sgroi D, Ellisen LW. DeYoung MP, et al. Genes Dev. 2008 Jan 15;22(2):239-51. doi: 10.1101/gad.1617608. Genes Dev. 2008. PMID: 18198340 Free PMC article.

7

A five-gene molecular grade index and HOXB13:IL17BR are complementary prognostic factors in early stage breast cancer.

Ma XJ, Salunga R, Dahiya S, Wang W, Carney E, Durbecq V, Harris A, Goss P, Sotiriou C, Erlander M, Sgroi D. Ma XJ, et al. Clin Cancer Res. 2008 May 1;14(9):2601-8. doi: 10.1158/1078-0432.CCR-07-5026. Clin Cancer Res. 2008. PMID: 18451222

8

Breast cancer SRC activity: bad to the bone.

Sgroi DC. Sgroi DC. Cancer Cell. 2009 Jul 7;16(1):1-2. doi: 10.1016/j.ccr.2009.06.010. Cancer Cell. 2009. PMID: 19573804 Free article.

9

Efficacy of neoadjuvant Cisplatin in triple-negative breast cancer.

Silver DP, Richardson AL, Eklund AC, Wang ZC, Szallasi Z, Li Q, Juul N, Leong CO, Calogrias D, Buraimoh A, Fatima A, Gelman RS, Ryan PD, Tung NM, De Nicolo A, Ganesan S, Miron A, Colin C, Sgroi DC, Ellisen LW, Winer EP, Garber JE. Silver DP, et al. Among authors: sgroi dc. J Clin Oncol. 2010 Mar 1;28(7):1145-53. doi: 10.1200/JCO.2009.22.4725. Epub 2010 Jan 25. J Clin Oncol. 2010. PMID: 20100965 Free PMC article.

10

Negative feedback control of HIF-1 through REDD1-regulated ROS suppresses tumorigenesis.

Horak P, Crawford AR, Vadysirisack DD, Nash ZM, DeYoung MP, Sgroi D, Ellisen LW. Horak P, et al. Proc Natl Acad Sci U S A. 2010 Mar 9;107(10):4675-80. doi: 10.1073/pnas.0907705107. Epub 2010 Feb 22. Proc Natl Acad Sci U S A. 2010. PMID: 20176937 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

214 results

Search Page

Filters